Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis

Narendranath Epperla; Qiuhong Zhao; Tamara Moyo; Marcus P. Watkins; Montreh Tavakkoli; Celeste Bello; Pallawi Torka; Nishitha Reddy; Colin Thomas; Kaitlin Annunzio; Beth Christian; Stefan K. Barta; Geoffrey Shouse; Adam J. Olszewski; Nancy L. Bartlett

doi:10.1182/bloodadvances.2023011698

Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis

Narendranath Epperla, Qiuhong Zhao, Tamara Moyo, Marcus P. Watkins, Montreh Tavakkoli, Celeste Bello, Pallawi Torka, Nishitha Reddy, Colin Thomas, Kaitlin Annunzio, Beth Christian, Stefan K. Barta, Geoffrey Shouse, Adam J. Olszewski, Nancy L. Bartlett

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	549-552
Number of pages	4
Journal	Blood Advances
Volume	8
Issue number	3
DOIs	https://doi.org/10.1182/bloodadvances.2023011698
State	Published - Feb 13 2024

Access to Document

10.1182/bloodadvances.2023011698

Cite this

Epperla, N., Zhao, Q., Moyo, T., Watkins, M. P., Tavakkoli, M., Bello, C., Torka, P., Reddy, N., Thomas, C., Annunzio, K., Christian, B., Barta, S. K., Shouse, G., Olszewski, A. J., & Bartlett, N. L. (2024). Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis. Blood Advances, 8(3), 549-552. https://doi.org/10.1182/bloodadvances.2023011698

@article{d3654d607bae4600aacf88ce89860d40,

title = "Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis",

author = "Narendranath Epperla and Qiuhong Zhao and Tamara Moyo and Watkins, {Marcus P.} and Montreh Tavakkoli and Celeste Bello and Pallawi Torka and Nishitha Reddy and Colin Thomas and Kaitlin Annunzio and Beth Christian and Barta, {Stefan K.} and Geoffrey Shouse and Olszewski, {Adam J.} and Bartlett, {Nancy L.}",

year = "2024",

month = feb,

day = "13",

doi = "10.1182/bloodadvances.2023011698",

language = "English",

volume = "8",

pages = "549--552",

journal = "Blood Advances",

issn = "2473-9529",

number = "3",

}

Epperla, N, Zhao, Q, Moyo, T, Watkins, MP, Tavakkoli, M, Bello, C, Torka, P, Reddy, N, Thomas, C, Annunzio, K, Christian, B, Barta, SK, Shouse, G, Olszewski, AJ & Bartlett, NL 2024, 'Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis', Blood Advances, vol. 8, no. 3, pp. 549-552. https://doi.org/10.1182/bloodadvances.2023011698

TY - JOUR

T1 - Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States

T2 - a real-world analysis

AU - Epperla, Narendranath

AU - Zhao, Qiuhong

AU - Moyo, Tamara

AU - Watkins, Marcus P.

AU - Tavakkoli, Montreh

AU - Bello, Celeste

AU - Torka, Pallawi

AU - Reddy, Nishitha

AU - Thomas, Colin

AU - Annunzio, Kaitlin

AU - Christian, Beth

AU - Barta, Stefan K.

AU - Shouse, Geoffrey

AU - Olszewski, Adam J.

AU - Bartlett, Nancy L.

PY - 2024/2/13

Y1 - 2024/2/13

UR - http://www.scopus.com/inward/record.url?scp=85185395343&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2023011698

DO - 10.1182/bloodadvances.2023011698

M3 - Letter

C2 - 38091577

AN - SCOPUS:85185395343

SN - 2473-9529

VL - 8

SP - 549

EP - 552

JO - Blood Advances

JF - Blood Advances

IS - 3

ER -

Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis

Access to Document

Other files and links

Cite this